Biocon quarterly net profit up 25 percent
April 28th, 2011 - 11:34 pm ICT by IANSNew Delhi, April 28 (IANS) Biotechnology firm Biocon Thursday posted a 25 percent increase in its consolidated net profit at Rs.100.81 crore for the quarter ended March 31 as against Rs.80.62 crore during the same period of the last fiscal.
The total income of the company stood at Rs.703.23 crore during the quarter under review as compared to Rs.658.21 crore during the like period of the corresponding fiscal.
“Financial year 2010-11 has delivered strong multi-sectoral growth. Licensing income from Pfizer and and others has contributed to profit generation this fiscal,” said Kiran Mazumdar Shaw, chairman and managing director, Biocon.
The company also said that it would divest its stake in its German subsidiary AxiCorp by the end of June.
AxiCorp was the licensee for Biocon’s biosimilar insulin and glargine in Germany and has the sole responsibility for commercialising these products.
“AxiCorp intends to focus keenly on growing the present businesses and during a transition period will continue to provide services to Biocon related to the clinical development of insulin and glargine in Europe,” the company said in a regulatory filing.
In order to support its expanding business, the company also has plans to increase its employee strength by around 1,000 in financial year 2012.
At the Bombay Stock Exchange the shares of the company closed down 3.61 percent at Rs.370.90.
- Biocon net profit up 20 percent in second quarter - Oct 22, 2010
- Biocon net up 25 percent for fourth quarter - Apr 28, 2011
- Biocon net marginally down in fiscal 2012 - Apr 27, 2012
- Biocon net up 33 percent in first quarter - Jul 23, 2010
- Biocon ties up with Pfizer to market biosimilars - Oct 18, 2010
- Pfizer snaps insulin marketing deal with Biocon - Mar 13, 2012
- Biocon net up 59 percent in first quarter - Jul 23, 2009
- Biocon quarterly net profit declines 29 percent - Apr 27, 2012
- Punjab National Bank quarterly net profit rises - May 04, 2011
- Axis Bank Q2 profit rises 38 percent to Rs.735.14 crore - Oct 14, 2010
- Axis Bank's net profit up 25.18 percent - Oct 22, 2011
- NTPC quarterly net profit rises 15 percent - Oct 25, 2011
- Reliance Capital nets 329 crore profit in Jan-March quarter - May 19, 2012
- ICICI Bank Q2 net profit rises 21.6 percent - Oct 31, 2011
- Axis Bank's quarterly net profit jumps 36 percent - Jan 17, 2011
Tags: biocon, biotechnology firm, bombay stock exchange, crore, german subsidiary, glargine, insulin, kiran mazumdar shaw, licensee, managing director, net profit, New Delhi, pfizer, profit generation, quarter ended march, sectoral growth, sole responsibility, stake, transition period, year 2012